Paul F. Lizzul, Chief Medical Officer at Sienna Biopharmaceuticals, Inc. (SNNA), bought 20,557 shares at $15.00 ($150K) on 2017-08-01, disclosed to the SEC on 2017-08-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 10,557 | $0 | 0.0% |
| 2 | $15.00 | 10,000 | $150K | 100.0% |
| Total | $7.30 avg | 20,557 | $150K | 100% |
| Filing → |
| ANAB | SELL | 2026-01-06 | $183K | — | Filing → |
| ANAB | SELL | 2025-12-23 | $75K | — | Filing → |
| ANAB | SELL | 2024-09-24 | $58K | — | Filing → |